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Management of biliopancreatic diseases has seen great prog-
ress in recent years. Innovations in endoscopy have allowed
gastroenterologists to assist in the care of many conditions
of the biliary tree and pancreas, which were previously only
managed surgically. Outcomes for many of these endoscopic
interventions are comparable to their surgical counterpart.
However, endoscopists taking care of these patients should
be well aware of the limitations of their procedures and the
advantages of surgery for certain patients.
This special issue will address some of the main chal-
lenges faced today by physicians taking care of patients with
pancreatic and biliary diseases. Endosonography, or endo-
scopic ultrasound (EUS), which previously was only consid-
ered a diagnostic tool, has now emerged as a useful thera-
peutic technique. In contrast, endoscopic retrograde cholan-
giopancreatography, or ERCP, has now become mainly a
therapeutic tool. Some ERCP techniques have been adopted
by endosonographers and allowed interventions for draining
bile ducts and peripancreatic ﬂuid collections, previously
considered outside the realm of endoscopy. Despite the
advances in outcomes and minimal invasiveness of EUS and
ERCP-guided interventions, several risks and complications
still remain. Pancreatitis is a well-recognized complication
of ERCP with a signiﬁcant incidence that has not been
reduced greatly throughout recent years. Numerous studies
have looked at ways of decreasing the risk of this dreadful
complication. This special issue will discuss and review the
problem of post-ERCP pancreatitis, a topic that raises a high
levelofconcernformanywhodothisprocedure,andwaysto
reduce its risk, especially in patients considered at high risk
for developing this complication.
Incidental pancreatic cysts continue to pose a diagnostic
dilemma for gastroenterologists and surgeons alike. Despite
the ability of safely obtaining a tissue sample during EUS
examination, the utility of cytopathology in determining the
exact nature of these lesions remains limited. More recently,
DNA analysis of ﬂuid obtained during aspiration has shown
promise in improving the diagnostic accuracy of EUS-FNA.
However, the eﬀect of these newer tests in terms of deciding
when to observe versus surgically resect in many of these
incidental cysts remains to be proven. Pancreatologists
agree that a reliable method for determining the nature
and prognosis of pancreatic cystic neoplasms is required
for improving the management strategy in asymptomatic
patients.
Abdominal pain is a cardinal symptom of chronic pan-
creatitis. The eﬀectiveness of medical therapy, in the form of
pancreatic enzyme supplementation or octreotide injections,
is dismal. Pain relief can certainly be obtained with the use
of narcotic medications, but at the cost of signiﬁcant side
eﬀects, such as constipation, sedation, and drug dependence.
Endoscopic alternatives for improving pain in chronic pan-
creatitis include those guided by ERCP, such as intraductal
stoneremoval,stricturedilation,ordrainageprocedures,and
EUS-guided celiac plexus block. This special issuewillreview
the ERCP-guided interventions and discuss the eﬃcacy of
EUS-guidedceliacplexusneurolysisforthetreatmentofpain
in patients with pancreatic cancer.2 Gastroenterology Research and Practice
As advances in endoscopy and surgical innovations are
introduced into the ﬁeld of biliary and pancreatic diseases,
many diseases previously requiring complicated surgeries
with prolonged recovery are now being managed by mini-
mally invasive techniques. Many of these procedures have a
reduced risk when compared to their surgical alternative.
However, long-term eﬃcacy and patient risk factors need
close consideration when deciding between diﬀerent man-
agement alternatives. Many, if not all, biliary and pancreatic
disorders require a close interaction between gastroenterol-
ogist and surgeon. The phrase “N om a ni sa ni s l a n d ”b y
John Donne (1572–1631) emphasizes the importance of
consensus between specialists and should always be in
the minds of those managing patients with biliopancreatic
diseases.
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